TS03 Inc Trust Units TSTIF

RE:RE:RE:Analyst reports.

[eunice12]

Unless Rumble gave them contract details not listed in the nr, they don't know more than us. Likely the increased targets are from tweaking the arbitrary discount rate with a tiny reduction. The really interesting analyst reports will come out after next month's FDA filing gets approved which could be in a month or two after. Currently they give TOS zero valuation for the 1,000 sales that will result in the next year or so from this approval.